V

Varex Imaging Corp
NASDAQ:VREX

Watchlist Manager
Varex Imaging Corp
NASDAQ:VREX
Watchlist
Price: 13.15 USD -0.15%
Market Cap: $551.2m

Varex Imaging Corp
Investor Relations

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,100 full-time employees. The company went IPO on 2017-01-20. The company operates through two segments: Medical and Industrial. The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, three-dimensional (3D) reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers and buckys. These components are used in a range of medical imaging applications. The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in various markets, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing and inspection applications used in various other markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Feb 10, 2026
AI Summary
Q1 2026

Strong Start: Varex reported Q1 revenue of $210 million, up 5% year-over-year and at the high end of guidance, with robust performance from the Industrial segment.

Industrial Growth: Industrial segment revenue rose 17% year-over-year, driven by strong cargo security system sales and broad-based demand.

Stable Medical Segment: Medical segment revenue was flat year-over-year, with particular strength in CT and growing interest in new system designs.

Margins & Profitability: Non-GAAP gross margin reached 34%, at the high end of guidance, and non-GAAP EPS grew to $0.19 from $0.10 last year.

China Revenue: Sales to China contributed 17% of total revenue and are expected to remain stable to slightly up for the full year.

Q2 Guidance: Second quarter revenue is expected between $210 million and $225 million, with non-GAAP EPS forecast at $0.15 to $0.25 per share.

India Operations: Ramp-up of detector and tube manufacturing in India is underway, generating customer interest despite short-term P&L impact.

Inventory Build: Inventory increased to support anticipated Industrial demand and new product ramps, with normalization targeted in coming quarters.

Key Financials
Revenue
$210 million
Industrial Segment Revenue
$65 million
Medical Segment Revenue
$145 million
Gross Margin
33%
Non-GAAP Gross Margin
34%
Operating Expenses
$52 million
Operating Income
$19 million
Operating Margin
9%
Net Income
$8 million
EPS
$0.19
Non-GAAP EPS
$0.19
Tax Rate
27%
Adjusted EBITDA
$29 million
Accounts Receivable
decreased by $10 million
Days Sales Outstanding
64 days
Inventory
$328 million
Days of Inventory
214 days
Accounts Payable
increased by $9 million
Days Payable
51 days
Net Cash from Operations
($16 million) outflow
Cash, Equivalents and Marketable Securities
$126 million
Gross Debt Outstanding
$370 million
Net Debt
$244 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Sunny S. Sanyal
President, CEO & Director
No Bio Available
Mr. Shubham Maheshwari
CFO & Principal Accounting Officer
No Bio Available
Ms. Kimberley E. Honeysett J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
No Bio Available
Mr. Mark S. Jonaitis
Senior VP & GM of X-Ray Sources
No Bio Available
Mr. Andrew J. Hartmann
Senior VP & GM of X-ray Detectors
No Bio Available
Mr. Christopher John Belfiore
Director of Investor Relations
No Bio Available
David Carmona
Vice President of Medical Global Sales & Marketing
No Bio Available
Ms. Karen Aranki
Chief Human Resources Officer
No Bio Available
Mr. Shaohua Liang
VP & MD for China
No Bio Available

Contacts

Address
UTAH
Salt Lake City
1678 S Pioneer Rd
Contacts
+18019725000.0
www.vareximaging.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett